Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-25-000253
Filing Date
2025-03-27
Accepted
2025-03-27 16:31:21
Documents
12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS gild013520-defa14a.htm DEFA14A 47397
2 GRAPHIC check01.jpg GRAPHIC 1441
3 GRAPHIC uncheck.jpg GRAPHIC 1060
4 GRAPHIC logo.jpg GRAPHIC 12727
5 GRAPHIC logo1.jpg GRAPHIC 8748
6 GRAPHIC lgild2025_defa14ax1x2.jpg GRAPHIC 37217
7 GRAPHIC lgild2025_defa14ax1x3.jpg GRAPHIC 4953
8 GRAPHIC lgild2025_defa14ax1x6.jpg GRAPHIC 3355
9 GRAPHIC lgild2025_defa14ax1x5.jpg GRAPHIC 5704
10 GRAPHIC lgild2025_defa14ax1x4.jpg GRAPHIC 5060
11 GRAPHIC lgild2025_defa14ax2x1.jpg GRAPHIC 1130
12 GRAPHIC lgild2025_defa14ax2x2.jpg GRAPHIC 1114
  Complete submission text file 0001308179-25-000253.txt   163795
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19731 | Film No.: 25779924
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)